Studies show therapies administered early have their greatest impact, whether these be medicinal or behavioral. Our team is focused on finding what works, and quickly moving on from what doesn’t.

Instead of raising funds and hoping the best researchers apply for them, we’re taking a different, qualitative and quantitative approach, working with the leading experts in pediatric genetics to fund the highest impact projects, specifically targeted toward therapeutic development.